Brooks Moore & Associates’s Encompass Health EHC Stock Holding History

Brooks Moore & Associates’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$419K	Buy	4,145 +100	+2%	+$10.4K	0.19%	84
2026 Q1	$391K	Sell	4,045 -200	-5%	-$20.5K	0.2%	82
2025 Q4	$451K	Buy	4,245 +700	+20%	+$81.1K	0.22%	76
2025 Q3	$450K	Sell	3,545 -612	-15%	-$72.9K	0.23%	75
2025 Q2	$458K	Sell	4,157 -338	-8%	-$38.6K	0.25%	75
2025 Q1	$455K	Hold	4,495	–	–	0.26%	75
2024 Q4	$415K	Hold	4,495	–	–	0.25%	72
2024 Q3	$434K	Hold	4,495	–	–	0.26%	71
2024 Q2	$386K	Hold	4,495	–	–	0.25%	70
2024 Q1	$371K	Sell	4,495 -60	-1%	-$4.39K	0.24%	71
2023 Q4	$304K	Hold	4,555	–	–	0.21%	69
2023 Q3	$306K	Hold	4,555	–	–	0.23%	67
2023 Q2	$308K	Hold	4,555	–	–	0.22%	69
2023 Q1	$246K	Hold	4,555	–	–	0.18%	77
2022 Q4	$272K	Hold	4,555	–	–	0.2%	77
2022 Q3	$206K	Sell	4,555 -1,171	-20%	-$58.6K	0.17%	80
2022 Q2	$255K	Hold	5,726	–	–	0.18%	78
2022 Q1	$324K	Sell	5,726 -14,543	-72%	-$759K	0.2%	78
2021 Q4	$1.05M	Buy	20,269 +14,041	+225%	+$724K	0.62%	45
2021 Q3	$372K	Hold	6,228	–	–	0.24%	74
2021 Q2	$387K	Hold	6,228	–	–	0.25%	75
2021 Q1	$406K	Sell	6,228 -965	-13%	-$62.9K	0.28%	72
2020 Q4	$473K	Hold	7,193	–	–	0.37%	66
2020 Q3	$372K	Hold	7,193	–	–	0.32%	66
2020 Q2	$354K	Hold	7,193	–	–	0.33%	68
2020 Q1	$366K	Hold	7,193	–	–	0.39%	69
2019 Q4	$396K	Hold	7,193	–	–	0.31%	74
2019 Q3	$362K	Hold	7,193	–	–	0.31%	76
2019 Q2	$363K	Hold	7,193	–	–	0.31%	78
2019 Q1	$334K	Sell	7,193 -71	-1%	-$3.6K	0.3%	75
2018 Q4	$357K	Buy	+7,264	New	+$413K	0.36%	67

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brooks Moore & Associates's EHC Position: Q2 2026 in Review

Brooks Moore & Associates increased its Encompass Health (EHC) stake by 2.5% in Q2 2026, buying an estimated $10.4K and bringing the position to 4,145 shares worth $419K. The position accounts for 0.19% of the portfolio, ranked #84.

Brooks Moore & Associates first reported a position in EHC in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.05M in Q4 2021. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Brooks Moore & Associates held 4,145 shares of Encompass Health worth $419K as of Q2 2026.
Brooks Moore & Associates bought 100 Encompass Health shares in Q2 2026, an estimated $10.4K.
Encompass Health made up 0.19% of Brooks Moore & Associates's portfolio in Q2 2026, its #84 holding.
Brooks Moore & Associates first reported a position in Encompass Health in Q4 2018 and has held it in 31 quarters since.
Brooks Moore & Associates's Encompass Health position peaked at $1.05M in Q4 2021.
598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Brooks Moore & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.